Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Women are more likely to have long-term post-COVID symptoms than men.

Testosterone may influence COVID-19 severity and outcomes.

Prostanoids, like prostaglandins and thromboxane A2, can both enhance and inhibit hair growth, and understanding their effects could help treat hair disorders.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

The study suggests that analyzing DNA can help treat hair loss, but more research is needed.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 infection can significantly cause temporary hair loss.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.